Company Overview

PRIME exits® and American HealthCare Capital are exclusively representing a rapidly growing, founder-led FDA-registered contract manufacturer and private label cosmetics producer for sale, headquartered in the Greater Philadelphia area. The Company formulates, manufactures, and packages a wide range of skincare, haircare, and body care products for both emerging and established beauty brands, operating through a vertically integrated model that combines R&D formulation, regulatory support, manufacturing, filling, packaging, and design under one roof.

Financial Overview

Revenue has grown from $5.5 million in 2023 to $11.2 million in 2025, with the Company’s 2026 year-to-date performance pacing toward approximately $14 million on an annualized basis. EBITDA margins have expanded steadily over the same period, and normalized full-year 2026 EBITDA is expected to track to approximately $7.5 million, reflecting both top-line growth and meaningful operating leverage.

Exit Plan

Ownership is planning for retirement and is seeking the right strategic or capital partner to scale the platform. The founders are open to remaining involved during a transition period to ensure operational continuity and customer retention. The Company is debt-light and asset-backed, with owner-controlled real estate that may be included in a transaction or leased back, depending on buyer preference.

Asking Price

The asking price is $30 million Enterprise Value. Qualified buyers may request the full Confidential Information Memorandum following execution of a confidentiality agreement